Codiak BioSciences, Inc. Revenue
Codiak BioSciences, Inc. reported Revenue of $522.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2022-11-03
- Codiak BioSciences, Inc. revenues for the quarter ending 2022-09-30 was $522.00K, a 54.88% decline year-over-year.
- Codiak BioSciences, Inc. revenues for the quarter ending 2022-06-30 was $13.14M, a 1376.97% increase year-over-year.
- Codiak BioSciences, Inc. revenues for the quarter ending 2022-03-31 was $12.70M, a 3.69% decline year-over-year.
- Codiak BioSciences, Inc. revenues for the quarter ending 2021-12-31 was $7.70M, a 369.33% increase year-over-year.
- Codiak BioSciences, Inc. revenues for fiscal 2021 was $22.93M, a 686.79% increase from fiscal 2020.
- Codiak BioSciences, Inc. revenues for fiscal 2020 was $2.92M, a 651.29% increase from fiscal 2019.
- Codiak BioSciences, Inc. revenues for fiscal 2019 was $388.00K.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2022-09-30 | $522.00K 10-Q · filed 2022-11-03 | $13.67M derived: sum of 2 quarters · filed 2022-11-03 | $26.37M 10-Q · filed 2022-11-03 | $34.07M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $13.14M 10-Q · filed 2022-08-04 | $25.85M 10-Q · filed 2022-08-04 | $33.55M derived: sum of 3 quarters · filed 2022-08-04 | $34.70M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | $12.70M 10-Q · filed 2022-05-05 | $20.40M derived: sum of 2 quarters · filed 2022-05-05 | $21.56M derived: sum of 3 quarters · filed 2022-11-03 | $22.45M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $8.85M derived: sum of 2 quarters · filed 2022-11-03 | $9.74M derived: sum of 3 quarters · filed 2022-11-03 | $22.93M 10-K · filed 2022-03-10 |
| 2021-09-30 | $1.16M 10-Q · filed 2022-11-03 | $2.05M derived: sum of 2 quarters · filed 2022-11-03 | $15.24M 10-Q · filed 2022-11-03 | $16.88M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $890.00K 10-Q · filed 2022-08-04 | $14.08M 10-Q · filed 2022-08-04 | $15.72M derived: sum of 3 quarters · filed 2022-08-04 | $16.68M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $13.19M 10-Q · filed 2022-05-05 | $14.83M derived: sum of 2 quarters · filed 2022-05-05 | $15.79M derived: sum of 3 quarters · filed 2022-05-05 | $15.97M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.59M derived: sum of 2 quarters · filed 2022-03-10 | $2.78M derived: sum of 3 quarters · filed 2022-03-10 | $2.92M 10-K · filed 2022-03-10 |
| 2020-09-30 | $954.00K 10-Q · filed 2021-11-04 | $1.14M derived: sum of 2 quarters · filed 2021-11-04 | $1.27M 10-Q · filed 2021-11-04 | $1.43M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $187.00K 10-Q · filed 2021-08-05 | $321.00K 10-Q · filed 2021-08-05 | $471.00K derived: sum of 3 quarters · filed 2021-08-05 | $622.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $134.00K 10-Q · filed 2021-05-06 | $284.00K derived: sum of 2 quarters · filed 2021-05-06 | $435.00K derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $301.00K derived: sum of 2 quarters · filed 2021-03-17 | $388.00K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $151.00K 10-Q · filed 2020-11-19 | $238.00K 10-Q · filed 2020-11-19 |